Lehrstuhl für Innere Medizin V

BKPYV-SPECIFIC T CELLS REDUCE VIRAL LOAD IN A PRIMARY TUBULAR CELL MODEL (2021) Wasielewski E, Lippler S, Knaup K, Gary R, Aigner M, Kremer AL, Pfister F, et al. Conference contribution Human CD22-transgenic, primary murine lymphoma challenges immunotherapies in organ-specific tumor microenvironments (2021) Gsottberger F, Brandl C, Wendland K, Petkovic S, Emmerich C, Erber R, Geppert CI, et al. Journal article The CAR-HEMATOTOX model identifies patients with a high risk for CAR T-cell related hematotoxicity and is associated with prolonged hospitalization and poor prognosis (2021) Rejeski K, Perez A, Sesques P, Berger C, Jentzsch L, Mougiakakos D, Froelich L, et al. Conference contribution Clinical phenotypes of CAR-T-cell related hematotoxicity in relapsed/refractory large B-cell lymphoma (2021) Rejeski K, Sesques P, Berger C, Jentzsch L, Mougiakakos D, Froelich L, Bucklein , et al. Conference contribution Control of PD-L1 expression in CLL-cells by stromal triggering of the Notch-c-Myc-EZH2 oncogenic signaling axis (2021) Böttcher M, Bruns H, Lu J, Chartomatsidou E, Papakonstantinou N, Mentz K, Büttner-Herold M, et al. Conference contribution CD137 (4-1BB) triggering leads to metabolic and functional reprogramming of human monocytes/macrophages enhancing their tumoricidal activity (2021) Stoll A, Bruns H, Gamali S, Saul D, Fuchs M, Nimmerjahn F, Kunz M, et al. Conference contribution How does phagocytosis affect macrophages? (2021) Biedermann A, Flamann C, Mougiakakos D, Bitterer K, Leffler M, Kellner C, Peipp M, et al. Conference contribution A20 as a novel prognostic factor for recurrence and patients' survival in oral squamous cell carcinoma (2021) Spörl S, Erber R, Gerken M, Fischer R, Taxis J, Meier JK, Geppert CI, et al. Conference contribution Effect of Idelalisib on PKC beta/NF-kappa B regulation in stromal cells of chronic lymphocytic leukemia (2021) Lutzny-Geier G, Handl SA, Von Heydebrand F, Wilke J, Kremer AL, Mackensen A, Völkl S Conference contribution Deciphering the role of HLA-DO in immune responses after allogeneic stem cell transplantation (2021) Zeun J, Flamann C, Neubeck S, Bausenwein J, Seyler L, Vogler T, Brey S, et al. Conference contribution